Similar articles

• Moloney murine leukemia virus integration protein produced in yeast binds specifically to viral att sites.

  Basu S, Varmus HE. Basu S, et al. J Virol. 1990 Nov;64(11):5617-25. doi: 10.1128/JVI.64.11.5617-5625.1990. J Virol. 1990. Retraction in: J Virol. 1991 Dec;65(12):7086. doi: 10.1128/JVI.65.12.7086-.1991. PMID: 2214028 Free PMC article. Retracted.
• Moloney murine leukemia virus IN protein from disrupted virions binds and specifically cleaves its target sequence in vitro.

  Ishimoto LK, Halperin M, Champoux JJ. Ishimoto LK, et al. Virology. 1991 Feb;180(2):527-34. doi: 10.1016/0042-6822(91)90066-k. Virology. 1991. PMID: 1989383
• The integration sites of endogenous and exogenous Moloney murine leukemia virus.

  van der Putten H, Terwindt E, Berns A, Jaenisch R. van der Putten H, et al. Cell. 1979 Sep;18(1):109-16. doi: 10.1016/0092-8674(79)90359-3. Cell. 1979. PMID: 509516
• Suppression of murine retrovirus polypeptide termination: effect of amber suppressor tRNA on the cell-free translation of Rauscher murine leukemia virus, Moloney murine leukemia virus, and Moloney murine sarcoma virus 124 RNA.

  Murphy EC Jr, Wills N, Arlinghaus RB. Murphy EC Jr, et al. J Virol. 1980 May;34(2):464-73. doi: 10.1128/JVI.34.2.464-473.1980. J Virol. 1980. PMID: 7373716 Free PMC article.
• In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.

  Ng AK, Ames RS Jr, McIntire RK, Herberman RB. Ng AK, et al. Cancer Res. 1979 Dec;39(12):4887-93. Cancer Res. 1979. PMID: 387218